Patient advocates in remission from MCL and FL discuss their experiences with treatment, as well as their views on CAR-T therapy’s place in managing blood cancers.
There are a range of cost-containment measures across the bill that will create a significant healthcare system shakeup.
The partnership is an extension of over 12 months of technical engagement between the two companies.
Cellares will adapt and automate the SBT-77-7101 manufacturing process from Sonoma for use with Cell Shuttle.
The proposed rule would allow multiple manufacturing units at different locations to register as one establishment.
Takeda plans to invest up to $30m to begin establishing an ecosystem for PDMPs and a plasma donation pilot.
